MicroBiopharm Japan Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
359
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
- Investments
-
1
MicroBiopharm Japan General Information
Description
Provider of contract manufacturing services using proprietary production technology intended to contribute to healthcare by applying the natural power of microorganisms. The company produces fine specialty chemicals and pharmaceuticals, especially anti-cancer drugs, as well as active ingredients for foods, animal feeds and agricultural products, in the use of fermentation, bioconversion and other specialized technologies, thereby enabling clients to meet the needs of pharmaceutical manufacturing around the world.
Contact Information
Website
www.microbiopharm.com(Operating Subsidiary)
Corporate Office
- 1-3-1 Kyobashi
- Chuo-ku
- Tokyo, 104-0031
- Japan
Corporate Office
- 1-3-1 Kyobashi
- Chuo-ku
- Tokyo, 104-0031
- Japan
MicroBiopharm Japan Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MicroBiopharm Japan Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
MicroBiopharm Japan Patents
MicroBiopharm Japan Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2026109774-A | Method for producing epirubicin hydrochloride crystals | Pending | 20-Dec-2024 | ||
| WO-2026134284-A1 | Production method for crystals of epirubicin hydrochloride | Pending | 20-Dec-2024 | ||
| JP-2025151828-A | Manufacturing method of smtp | Pending | 28-Mar-2024 | ||
| WO-2025206248-A1 | Smtp production method | Pending | 28-Mar-2024 | ||
| WO-2024075764-A1 | Method for manufacturing antibody-drug conjugate and enzyme used in same | Inactive | 05-Oct-2022 |
MicroBiopharm Japan Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MicroBiopharm Japan Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
MicroBiopharm Japan Investments (1)
MicroBiopharm Japan’s most recent deal was a Corporate Asset Purchase with Astellas Pharma (Manufacturing Plant in Kiyosu, Japan). The deal was made on 02-Nov-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Astellas Pharma (Manufacturing Plant in Kiyosu, Japan) | 02-Nov-2015 | Corporate Asset Purchase | Buildings and Property |
MicroBiopharm Japan FAQs
-
When was MicroBiopharm Japan founded?
MicroBiopharm Japan was founded in 2011.
-
Where is MicroBiopharm Japan headquartered?
MicroBiopharm Japan is headquartered in Tokyo, Japan.
-
What is the size of MicroBiopharm Japan?
MicroBiopharm Japan has 359 total employees.
-
What industry is MicroBiopharm Japan in?
MicroBiopharm Japan’s primary industry is BPO/Outsource Services.
-
Is MicroBiopharm Japan a private or public company?
MicroBiopharm Japan is a Private company.
-
What is the current valuation of MicroBiopharm Japan?
The current valuation of MicroBiopharm Japan is .
-
What is MicroBiopharm Japan’s current revenue?
The current revenue for MicroBiopharm Japan is .
-
Who are MicroBiopharm Japan’s investors?
Mercian, Mitsui & Co, T Capital Partners, and Toray Industries have invested in MicroBiopharm Japan.
-
When was MicroBiopharm Japan acquired?
MicroBiopharm Japan was acquired on 18-Sep-2026.
-
Who acquired MicroBiopharm Japan?
MicroBiopharm Japan was acquired by Gujarat Themis Biosyn.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
